Cambridge-based medtech startup PredictImmune raises £10 million in Series B round to treat immune-mediated diseases

PredictImmune, developers of prognostic tests for guiding treatment in immune-mediated diseases, closed its Series B round of funding at £10 million. The investment, led by Parkwalk and BFG, will enable global commercial expansion and enrich the firm’s product pipeline.    With the freshly raised capital, PredictImmune plans to continue its expansion across Europe and the US […]